Search Results 1461-1470 of 18681 for autoimmune hepatitis

  1. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    Participation eligibility · Patients with a positive hepatitis B core antibody but with negative hepatitis B DNA may participate, but must have hepatitis ...

  2. Zidovudine (oral route) - Mayo Clinic

    Liver disease (including hepatitis)—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Low amounts of ...

  3. Triple transplant: A unique opportunity to transform patients' lives - Mayo Clinic

    The converse also is true: Kidney or liver disease can precipitate heart failure. Though patient ages vary for triple transplant, eligible patients often are ...

  4. Living With Cancer: Hepatocellular carcinoma - Mayo Clinic News Network

    Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Fight ...

  5. Mayo Clinic Radio: Liver transplant and organ donation / clinical trials / constipation

    ... liver disease. In rare cases, sudden failure of a previously normal liver may occur. The liver is just one of several organs, including kidney, heart and ...

  6. Terlipressin (intravenous route) - Mayo Clinic

    Terlipressin injection is used to improve kidney function in patients with hepatorenal syndrome (kidney problem that occurs in patients with severe liver ...

  7. Avacopan (oral route) - Mayo Clinic

    Make sure you tell your doctor if you have any other medical problems, especially: Infection, severe and active or; Liver disease (eg, cirrhosis, hepatitis B or ...

  8. Emtricitabine, rilpivirine, and tenofovir alafenamide (oral route) - Mayo Clinic

    This is more common in patients with a history of hepatitis B or C infection or those who already have liver disease. ... Autoimmune disorders such as ...

  9. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

    Known active hepatitis B or hepatitis C; Active autoimmune disease that has required systemic treatment in the past 2 years (ie, with use of disease ...

  10. A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury - Mayo Clinic

    hepatitis. - Proteinuria greater than 500 mg/dL ... Liver Disease score were associated with better survival. ... liver disease. The aim of this study ...